Stomach Cancer and Gastric Cancer Treatment and Forecast Market
1 Introduction to Research & Analysis Reports
1.1 Stomach Cancer and Gastric Cancer Treatment Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Stomach Cancer and Gastric Cancer Treatment Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Stomach Cancer and Gastric Cancer Treatment Overall Market Size
2.1 Global Stomach Cancer and Gastric Cancer Treatment Market Size: 2021 VS 2028
2.2 Global Stomach Cancer and Gastric Cancer Treatment Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Stomach Cancer and Gastric Cancer Treatment Players in Global Market
3.2 Top Global Stomach Cancer and Gastric Cancer Treatment Companies Ranked by Revenue
3.3 Global Stomach Cancer and Gastric Cancer Treatment Revenue by Companies
3.4 Top 3 and Top 5 Stomach Cancer and Gastric Cancer Treatment Companies in Global Market, by Revenue in 2021
3.5 Global Companies Stomach Cancer and Gastric Cancer Treatment Product Type
3.6 Tier 1, Tier 2 and Tier 3 Stomach Cancer and Gastric Cancer Treatment Players in Global Market
3.6.1 List of Global Tier 1 Stomach Cancer and Gastric Cancer Treatment Companies
3.6.2 List of Global Tier 2 and Tier 3 Stomach Cancer and Gastric Cancer Treatment Companies
4 Market Sights by Product
4.1 Overview
4.1.1 by Type - Global Stomach Cancer and Gastric Cancer Treatment Market Size Markets, 2021 & 2028
4.1.2 Programmed Cell Death Protein 1 (PD-1) Inhibitors
4.1.3 Human Epidermal Growth Factor Receptor (HER2) Antagonists
4.1.4 Vascular Endothelial Growth Factor Receptor (VEGFR) Antagonists
4.1.5 Others
4.2 By Type - Global Stomach Cancer and Gastric Cancer Treatment Revenue & Forecasts
4.2.1 By Type - Global Stomach Cancer and Gastric Cancer Treatment Revenue, 2017-2022
4.2.2 By Type - Global Stomach Cancer and Gastric Cancer Treatment Revenue, 2023-2028
4.2.3 By Type - Global Stomach Cancer and Gastric Cancer Treatment Revenue Market Share, 2017-2028
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Stomach Cancer and Gastric Cancer Treatment Market Size, 2021 & 2028
5.1.2 Hospitals
5.1.3 Clinics
5.2 By Application - Global Stomach Cancer and Gastric Cancer Treatment Revenue & Forecasts
5.2.1 By Application - Global Stomach Cancer and Gastric Cancer Treatment Revenue, 2017-2022
5.2.2 By Application - Global Stomach Cancer and Gastric Cancer Treatment Revenue, 2023-2028
5.2.3 By Application - Global Stomach Cancer and Gastric Cancer Treatment Revenue Market Share, 2017-2028
6 Sights by Region
6.1 By Region - Global Stomach Cancer and Gastric Cancer Treatment Market Size, 2021 & 2028
6.2 By Region - Global Stomach Cancer and Gastric Cancer Treatment Revenue & Forecasts
6.2.1 By Region - Global Stomach Cancer and Gastric Cancer Treatment Revenue, 2017-2022
6.2.2 By Region - Global Stomach Cancer and Gastric Cancer Treatment Revenue, 2023-2028
6.2.3 By Region - Global Stomach Cancer and Gastric Cancer Treatment Revenue Market Share, 2017-2028
6.3 North America
6.3.1 By Country - North America Stomach Cancer and Gastric Cancer Treatment Revenue, 2017-2028
6.3.2 US Stomach Cancer and Gastric Cancer Treatment Market Size, 2017-2028
6.3.3 Canada Stomach Cancer and Gastric Cancer Treatment Market Size, 2017-2028
6.3.4 Mexico Stomach Cancer and Gastric Cancer Treatment Market Size, 2017-2028
6.4 Europe
6.4.1 By Country - Europe Stomach Cancer and Gastric Cancer Treatment Revenue, 2017-2028
6.4.2 Germany Stomach Cancer and Gastric Cancer Treatment Market Size, 2017-2028
6.4.3 France Stomach Cancer and Gastric Cancer Treatment Market Size, 2017-2028
6.4.4 U.K. Stomach Cancer and Gastric Cancer Treatment Market Size, 2017-2028
6.4.5 Italy Stomach Cancer and Gastric Cancer Treatment Market Size, 2017-2028
6.4.6 Russia Stomach Cancer and Gastric Cancer Treatment Market Size, 2017-2028
6.4.7 Nordic Countries Stomach Cancer and Gastric Cancer Treatment Market Size, 2017-2028
6.4.8 Benelux Stomach Cancer and Gastric Cancer Treatment Market Size, 2017-2028
6.5 Asia
6.5.1 By Region - Asia Stomach Cancer and Gastric Cancer Treatment Revenue, 2017-2028
6.5.2 China Stomach Cancer and Gastric Cancer Treatment Market Size, 2017-2028
6.5.3 Japan Stomach Cancer and Gastric Cancer Treatment Market Size, 2017-2028
6.5.4 South Korea Stomach Cancer and Gastric Cancer Treatment Market Size, 2017-2028
6.5.5 Southeast Asia Stomach Cancer and Gastric Cancer Treatment Market Size, 2017-2028
6.5.6 India Stomach Cancer and Gastric Cancer Treatment Market Size, 2017-2028
6.6 South America
6.6.1 By Country - South America Stomach Cancer and Gastric Cancer Treatment Revenue, 2017-2028
6.6.2 Brazil Stomach Cancer and Gastric Cancer Treatment Market Size, 2017-2028
6.6.3 Argentina Stomach Cancer and Gastric Cancer Treatment Market Size, 2017-2028
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Stomach Cancer and Gastric Cancer Treatment Revenue, 2017-2028
6.7.2 Turkey Stomach Cancer and Gastric Cancer Treatment Market Size, 2017-2028
6.7.3 Israel Stomach Cancer and Gastric Cancer Treatment Market Size, 2017-2028
6.7.4 Saudi Arabia Stomach Cancer and Gastric Cancer Treatment Market Size, 2017-2028
6.7.5 UAE Stomach Cancer and Gastric Cancer Treatment Market Size, 2017-2028
7 Players Profiles
7.1 Ipsen Pharma
7.1.1 Ipsen Pharma Corporate Summary
7.1.2 Ipsen Pharma Business Overview
7.1.3 Ipsen Pharma Stomach Cancer and Gastric Cancer Treatment Major Product Offerings
7.1.4 Ipsen Pharma Stomach Cancer and Gastric Cancer Treatment Revenue in Global Market (2017-2022)
7.1.5 Ipsen Pharma Key News
7.2 Merck & Co., Inc.
7.2.1 Merck & Co., Inc. Corporate Summary
7.2.2 Merck & Co., Inc. Business Overview
7.2.3 Merck & Co., Inc. Stomach Cancer and Gastric Cancer Treatment Major Product Offerings
7.2.4 Merck & Co., Inc. Stomach Cancer and Gastric Cancer Treatment Revenue in Global Market (2017-2022)
7.2.5 Merck & Co., Inc. Key News
7.3 Bristol-Myers Squibb Company
7.3.1 Bristol-Myers Squibb Company Corporate Summary
7.3.2 Bristol-Myers Squibb Company Business Overview
7.3.3 Bristol-Myers Squibb Company Stomach Cancer and Gastric Cancer Treatment Major Product Offerings
7.3.4 Bristol-Myers Squibb Company Stomach Cancer and Gastric Cancer Treatment Revenue in Global Market (2017-2022)
7.3.5 Bristol-Myers Squibb Company Key News
7.4 Eli Lilly
7.4.1 Eli Lilly Corporate Summary
7.4.2 Eli Lilly Business Overview
7.4.3 Eli Lilly Stomach Cancer and Gastric Cancer Treatment Major Product Offerings
7.4.4 Eli Lilly Stomach Cancer and Gastric Cancer Treatment Revenue in Global Market (2017-2022)
7.4.5 Eli Lilly Key News
7.5 Roche
7.5.1 Roche Corporate Summary
7.5.2 Roche Business Overview
7.5.3 Roche Stomach Cancer and Gastric Cancer Treatment Major Product Offerings
7.5.4 Roche Stomach Cancer and Gastric Cancer Treatment Revenue in Global Market (2017-2022)
7.5.5 Roche Key News
7.6 Novartis AG
7.6.1 Novartis AG Corporate Summary
7.6.2 Novartis AG Business Overview
7.6.3 Novartis AG Stomach Cancer and Gastric Cancer Treatment Major Product Offerings
7.6.4 Novartis AG Stomach Cancer and Gastric Cancer Treatment Revenue in Global Market (2017-2022)
7.6.5 Novartis AG Key News
7.7 Bayer AG
7.7.1 Bayer AG Corporate Summary
7.7.2 Bayer AG Business Overview
7.7.3 Bayer AG Stomach Cancer and Gastric Cancer Treatment Major Product Offerings
7.7.4 Bayer AG Stomach Cancer and Gastric Cancer Treatment Revenue in Global Market (2017-2022)
7.7.5 Bayer AG Key News
7.8 Celltrion Inc.
7.8.1 Celltrion Inc. Corporate Summary
7.8.2 Celltrion Inc. Business Overview
7.8.3 Celltrion Inc. Stomach Cancer and Gastric Cancer Treatment Major Product Offerings
7.8.4 Celltrion Inc. Stomach Cancer and Gastric Cancer Treatment Revenue in Global Market (2017-2022)
7.8.5 Celltrion Inc. Key News
7.9 TAIHO PHARMACEUTICAL CO., LTD.
7.9.1 TAIHO PHARMACEUTICAL CO., LTD. Corporate Summary
7.9.2 TAIHO PHARMACEUTICAL CO., LTD. Business Overview
7.9.3 TAIHO PHARMACEUTICAL CO., LTD. Stomach Cancer and Gastric Cancer Treatment Major Product Offerings
7.9.4 TAIHO PHARMACEUTICAL CO., LTD. Stomach Cancer and Gastric Cancer Treatment Revenue in Global Market (2017-2022)
7.9.5 TAIHO PHARMACEUTICAL CO., LTD. Key News
7.10 Jiangsu Hengrui Medicine Co., Ltd.
7.10.1 Jiangsu Hengrui Medicine Co., Ltd. Corporate Summary
7.10.2 Jiangsu Hengrui Medicine Co., Ltd. Business Overview
7.10.3 Jiangsu Hengrui Medicine Co., Ltd. Stomach Cancer and Gastric Cancer Treatment Major Product Offerings
7.10.4 Jiangsu Hengrui Medicine Co., Ltd. Stomach Cancer and Gastric Cancer Treatment Revenue in Global Market (2017-2022)
7.10.5 Jiangsu Hengrui Medicine Co., Ltd. Key News
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
List of Tables
Table 1. Stomach Cancer and Gastric Cancer Treatment Market Opportunities & Trends in Global Market
Table 2. Stomach Cancer and Gastric Cancer Treatment Market Drivers in Global Market
Table 3. Stomach Cancer and Gastric Cancer Treatment Market Restraints in Global Market
Table 4. Key Players of Stomach Cancer and Gastric Cancer Treatment in Global Market
Table 5. Top Stomach Cancer and Gastric Cancer Treatment Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Stomach Cancer and Gastric Cancer Treatment Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Stomach Cancer and Gastric Cancer Treatment Revenue Share by Companies, 2017-2022
Table 8. Global Companies Stomach Cancer and Gastric Cancer Treatment Product Type
Table 9. List of Global Tier 1 Stomach Cancer and Gastric Cancer Treatment Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Stomach Cancer and Gastric Cancer Treatment Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type ? Global Stomach Cancer and Gastric Cancer Treatment Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Stomach Cancer and Gastric Cancer Treatment Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Stomach Cancer and Gastric Cancer Treatment Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application ? Global Stomach Cancer and Gastric Cancer Treatment Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Stomach Cancer and Gastric Cancer Treatment Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Stomach Cancer and Gastric Cancer Treatment Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region ? Global Stomach Cancer and Gastric Cancer Treatment Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Stomach Cancer and Gastric Cancer Treatment Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Stomach Cancer and Gastric Cancer Treatment Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Stomach Cancer and Gastric Cancer Treatment Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Stomach Cancer and Gastric Cancer Treatment Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Stomach Cancer and Gastric Cancer Treatment Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Stomach Cancer and Gastric Cancer Treatment Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Stomach Cancer and Gastric Cancer Treatment Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Stomach Cancer and Gastric Cancer Treatment Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Stomach Cancer and Gastric Cancer Treatment Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Stomach Cancer and Gastric Cancer Treatment Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Stomach Cancer and Gastric Cancer Treatment Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Stomach Cancer and Gastric Cancer Treatment Revenue, (US$, Mn), 2023-2028
Table 30. Ipsen Pharma Corporate Summary
Table 31. Ipsen Pharma Stomach Cancer and Gastric Cancer Treatment Product Offerings
Table 32. Ipsen Pharma Stomach Cancer and Gastric Cancer Treatment Revenue (US$, Mn), (2017-2022)
Table 33. Merck & Co., Inc. Corporate Summary
Table 34. Merck & Co., Inc. Stomach Cancer and Gastric Cancer Treatment Product Offerings
Table 35. Merck & Co., Inc. Stomach Cancer and Gastric Cancer Treatment Revenue (US$, Mn), (2017-2022)
Table 36. Bristol-Myers Squibb Company Corporate Summary
Table 37. Bristol-Myers Squibb Company Stomach Cancer and Gastric Cancer Treatment Product Offerings
Table 38. Bristol-Myers Squibb Company Stomach Cancer and Gastric Cancer Treatment Revenue (US$, Mn), (2017-2022)
Table 39. Eli Lilly Corporate Summary
Table 40. Eli Lilly Stomach Cancer and Gastric Cancer Treatment Product Offerings
Table 41. Eli Lilly Stomach Cancer and Gastric Cancer Treatment Revenue (US$, Mn), (2017-2022)
Table 42. Roche Corporate Summary
Table 43. Roche Stomach Cancer and Gastric Cancer Treatment Product Offerings
Table 44. Roche Stomach Cancer and Gastric Cancer Treatment Revenue (US$, Mn), (2017-2022)
Table 45. Novartis AG Corporate Summary
Table 46. Novartis AG Stomach Cancer and Gastric Cancer Treatment Product Offerings
Table 47. Novartis AG Stomach Cancer and Gastric Cancer Treatment Revenue (US$, Mn), (2017-2022)
Table 48. Bayer AG Corporate Summary
Table 49. Bayer AG Stomach Cancer and Gastric Cancer Treatment Product Offerings
Table 50. Bayer AG Stomach Cancer and Gastric Cancer Treatment Revenue (US$, Mn), (2017-2022)
Table 51. Celltrion Inc. Corporate Summary
Table 52. Celltrion Inc. Stomach Cancer and Gastric Cancer Treatment Product Offerings
Table 53. Celltrion Inc. Stomach Cancer and Gastric Cancer Treatment Revenue (US$, Mn), (2017-2022)
Table 54. TAIHO PHARMACEUTICAL CO., LTD. Corporate Summary
Table 55. TAIHO PHARMACEUTICAL CO., LTD. Stomach Cancer and Gastric Cancer Treatment Product Offerings
Table 56. TAIHO PHARMACEUTICAL CO., LTD. Stomach Cancer and Gastric Cancer Treatment Revenue (US$, Mn), (2017-2022)
Table 57. Jiangsu Hengrui Medicine Co., Ltd. Corporate Summary
Table 58. Jiangsu Hengrui Medicine Co., Ltd. Stomach Cancer and Gastric Cancer Treatment Product Offerings
Table 59. Jiangsu Hengrui Medicine Co., Ltd. Stomach Cancer and Gastric Cancer Treatment Revenue (US$, Mn), (2017-2022)
List of Figures
Figure 1. Stomach Cancer and Gastric Cancer Treatment Segment by Type in 2021
Figure 2. Stomach Cancer and Gastric Cancer Treatment Segment by Application in 2021
Figure 3. Global Stomach Cancer and Gastric Cancer Treatment Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Stomach Cancer and Gastric Cancer Treatment Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Stomach Cancer and Gastric Cancer Treatment Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Stomach Cancer and Gastric Cancer Treatment Revenue in 2021
Figure 8. By Type - Global Stomach Cancer and Gastric Cancer Treatment Revenue Market Share, 2017-2028
Figure 9. By Application - Global Stomach Cancer and Gastric Cancer Treatment Revenue Market Share, 2017-2028
Figure 10. By Region - Global Stomach Cancer and Gastric Cancer Treatment Revenue Market Share, 2017-2028
Figure 11. By Country - North America Stomach Cancer and Gastric Cancer Treatment Revenue Market Share, 2017-2028
Figure 12. US Stomach Cancer and Gastric Cancer Treatment Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Stomach Cancer and Gastric Cancer Treatment Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Stomach Cancer and Gastric Cancer Treatment Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Stomach Cancer and Gastric Cancer Treatment Revenue Market Share, 2017-2028
Figure 16. Germany Stomach Cancer and Gastric Cancer Treatment Revenue, (US$, Mn), 2017-2028
Figure 17. France Stomach Cancer and Gastric Cancer Treatment Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Stomach Cancer and Gastric Cancer Treatment Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Stomach Cancer and Gastric Cancer Treatment Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Stomach Cancer and Gastric Cancer Treatment Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Stomach Cancer and Gastric Cancer Treatment Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Stomach Cancer and Gastric Cancer Treatment Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Stomach Cancer and Gastric Cancer Treatment Revenue Market Share, 2017-2028
Figure 24. China Stomach Cancer and Gastric Cancer Treatment Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Stomach Cancer and Gastric Cancer Treatment Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Stomach Cancer and Gastric Cancer Treatment Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Stomach Cancer and Gastric Cancer Treatment Revenue, (US$, Mn), 2017-2028
Figure 28. India Stomach Cancer and Gastric Cancer Treatment Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Stomach Cancer and Gastric Cancer Treatment Revenue Market Share, 2017-2028
Figure 30. Brazil Stomach Cancer and Gastric Cancer Treatment Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Stomach Cancer and Gastric Cancer Treatment Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Stomach Cancer and Gastric Cancer Treatment Revenue Market Share, 2017-2028
Figure 33. Turkey Stomach Cancer and Gastric Cancer Treatment Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Stomach Cancer and Gastric Cancer Treatment Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Stomach Cancer and Gastric Cancer Treatment Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Stomach Cancer and Gastric Cancer Treatment Revenue, (US$, Mn), 2017-2028
Figure 37. Ipsen Pharma Stomach Cancer and Gastric Cancer Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Merck & Co., Inc. Stomach Cancer and Gastric Cancer Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Bristol-Myers Squibb Company Stomach Cancer and Gastric Cancer Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Eli Lilly Stomach Cancer and Gastric Cancer Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Roche Stomach Cancer and Gastric Cancer Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. Novartis AG Stomach Cancer and Gastric Cancer Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. Bayer AG Stomach Cancer and Gastric Cancer Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. Celltrion Inc. Stomach Cancer and Gastric Cancer Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 45. TAIHO PHARMACEUTICAL CO., LTD. Stomach Cancer and Gastric Cancer Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 46. Jiangsu Hengrui Medicine Co., Ltd. Stomach Cancer and Gastric Cancer Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
